S. Wolf

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.

Mufaddal Mamawala, Bruce J Trock, H Ballentine Carter, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. Tosoian JJ, Mamawala M, Epstein JI, Landis P, Wolf S, Trock BJ, Carter HB.J Clin Oncol. 2015 Oct 20;33(30):3379-85. [Epub 2015 Aug 31]. doi: 10.1200/JCO.2015.62.5764.

J. Epstein, H. Carter, M. Mamawala, 2017, Urologic oncology.

The Role of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy in Active Surveillance.

K. Macura, J. Epstein, J. Tosoian, 2017, European urology.

Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance

Jonathan I. Epstein, Mufaddal Mamawala, L. Sokoll, 2017, Prostate Cancer and Prostatic Diseases.

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

L. Sokoll, J. Tosoian, E. Schaeffer, 2016, Urology case reports.